• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子α受体1信号通路的消融可减轻过氧化物酶体增殖物激活受体α缺陷小鼠的脂肪性肝炎。

Ablation of Tumor Necrosis Factor Alpha Receptor 1 Signaling Blunts Steatohepatitis in Peroxisome Proliferator Activated Receptor α-Deficient Mice.

作者信息

Hines Ian N, Milton Jamie, Kremer Michael, Wheeler Michael D

机构信息

Department of Nutrition Science, East Carolina University, North Carolina, USA.

Department of General and Visceral Surgery, Hospital of Aarau, Aarau, Switzerland.

出版信息

Med Res Arch. 2022 Oct;10(9). doi: 10.18103/mra.v10i9.3082. Epub 2022 Sep 20.

DOI:10.18103/mra.v10i9.3082
PMID:36865784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977327/
Abstract

Tumor necrosis factor -alpha (TNFα) is strongly associated with fatty liver disease (i.e, hepatosteatosis). Cytokine production has been thought of as a consequence of hepatic lipid accumulation which becomes a critical factor in the development of chronic liver pathologies as well as insulin resistance. The purpose of this study was to test the hypothesis that TNFα directly regulates lipid metabolism in liver in the mutant peroxisome-proliferator activated receptor-alpha (PPARα) mouse model with robust hepatic lipid accumulation. At 10 weeks of age, TNFα and TNF receptor 1 expression are increased in livers of PPARα mice compared to wild type. PPARα mice were then crossed with mice lacking the receptor for TNFα receptor 1 (TNFR1). Wild type, PPARα, TNFR1, PPARα x TNFR1 mice were housed on ad-libitum standard chow diet for up to 40 weeks. Increases in hepatic lipid and liver injury and metabolic disruption associated with PPARα ablation were largely blunted when PPARα mice were crossed with TNFR1 mice. These data support the hypothesis that TNFR1 signaling is critical for accumulation of lipid in liver. Therapies that reduce pro-inflammatory responses, namely TNFα, could have important clinical implications to reduce hepatosteatosis and progression of severe liver disease.

摘要

肿瘤坏死因子-α(TNFα)与脂肪性肝病(即肝脂肪变性)密切相关。细胞因子的产生被认为是肝脏脂质蓄积的结果,而肝脏脂质蓄积成为慢性肝脏疾病以及胰岛素抵抗发展的关键因素。本研究的目的是在具有大量肝脏脂质蓄积的突变型过氧化物酶体增殖物激活受体-α(PPARα)小鼠模型中,验证TNFα直接调节肝脏脂质代谢这一假说。在10周龄时,与野生型相比,PPARα小鼠肝脏中TNFα和TNF受体1的表达增加。然后将PPARα小鼠与缺乏TNFα受体1(TNFR1)的小鼠杂交。野生型、PPARα、TNFR1、PPARα×TNFR1小鼠自由采食标准饲料长达40周。当PPARα小鼠与TNFR1小鼠杂交时,与PPARα基因敲除相关的肝脏脂质增加、肝损伤和代谢紊乱在很大程度上得到缓解。这些数据支持TNFR1信号传导对肝脏脂质蓄积至关重要这一假说。减少促炎反应(即TNFα)的疗法可能对减少肝脂肪变性和严重肝病的进展具有重要的临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/79b10752b58f/nihms-1848013-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/dd8a9808e97b/nihms-1848013-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/6422e5af8b96/nihms-1848013-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/4390fd71a345/nihms-1848013-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/79b10752b58f/nihms-1848013-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/dd8a9808e97b/nihms-1848013-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/6422e5af8b96/nihms-1848013-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/4390fd71a345/nihms-1848013-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/9977327/79b10752b58f/nihms-1848013-f0004.jpg

相似文献

1
Ablation of Tumor Necrosis Factor Alpha Receptor 1 Signaling Blunts Steatohepatitis in Peroxisome Proliferator Activated Receptor α-Deficient Mice.肿瘤坏死因子α受体1信号通路的消融可减轻过氧化物酶体增殖物激活受体α缺陷小鼠的脂肪性肝炎。
Med Res Arch. 2022 Oct;10(9). doi: 10.18103/mra.v10i9.3082. Epub 2022 Sep 20.
2
Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.过氧化物酶体增殖物激活受体-α 选择性调节剂 K-877 能有效激活过氧化物酶体增殖物激活受体-α 通路,改善小鼠的脂代谢。
J Diabetes Investig. 2017 Jul;8(4):446-452. doi: 10.1111/jdi.12621. Epub 2017 Apr 25.
3
Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.膳食鱼油激活过氧化物酶体增殖物激活受体α可减轻脂肪变性,但由于肝脏脂质过氧化物积累,无法预防实验性脂肪性肝炎。
J Gastroenterol Hepatol. 2008 Feb;23(2):267-75. doi: 10.1111/j.1440-1746.2007.05157.x. Epub 2007 Sep 12.
4
Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.肿瘤坏死因子-α受体 1 信号通路的破坏可加速高脂饮食诱导的小鼠非酒精性脂肪性肝病进展。
J Nutr Biochem. 2018 Aug;58:17-27. doi: 10.1016/j.jnutbio.2018.04.013. Epub 2018 May 2.
5
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.肝源性 Krüppel 样因子 16(KLF16)靶向 PPARα 以改善脂肪性肝炎和胰岛素抵抗。
Gut. 2021 Nov;70(11):2183-2195. doi: 10.1136/gutjnl-2020-321774. Epub 2020 Nov 30.
6
Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice.肝细胞中肿瘤坏死因子-α受体 1 缺乏不能预防非酒精性脂肪性肝炎,但可减轻小鼠的胰岛素抵抗。
World J Gastroenterol. 2020 Sep 7;26(33):4933-4944. doi: 10.3748/wjg.v26.i33.4933.
7
Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis.小鼠中过氧化物酶体增殖物激活受体α的缺失会增强蛋氨酸和胆碱缺乏饮食诱导的脂肪性肝炎。
Hepatol Res. 2004 Oct;30(2):104-110. doi: 10.1016/j.hepres.2004.06.004.
8
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
9
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.过氧化物酶体增殖物激活受体-α激动剂 Wy 14,643 可改善非酒精性脂肪性肝炎糖尿病小鼠的代谢指标、脂肪变性和气球样变。
J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.
10
Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.过氧化物酶体增殖物激活受体-α基因水平差异影响载脂蛋白 E2 基因敲入小鼠的脂代谢和炎症反应。
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1573-9. doi: 10.1161/ATVBAHA.110.220525. Epub 2011 Apr 7.

引用本文的文献

1
The role of mitochondrial function in the pathogenesis of diabetes.线粒体功能在糖尿病发病机制中的作用。
Front Endocrinol (Lausanne). 2025 Aug 8;16:1607641. doi: 10.3389/fendo.2025.1607641. eCollection 2025.
2
Regulation of hepatic Sirt1 expression and lipid metabolism through TNF receptor signaling.通过肿瘤坏死因子受体信号传导调节肝脏Sirt1表达和脂质代谢。
Front Immunol. 2025 Jul 22;16:1627433. doi: 10.3389/fimmu.2025.1627433. eCollection 2025.
3
Effects of Hayata juice on high-fat diet-induced obesity in HBV transgenic mice.

本文引用的文献

1
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.非酒精性脂肪性肝病:代谢、微生物和免疫之间的相互作用。
Nat Metab. 2021 Dec;3(12):1596-1607. doi: 10.1038/s42255-021-00501-9. Epub 2021 Dec 20.
2
Innate immune cells and their interaction with T cells in hepatocellular carcinoma.肝细胞癌中固有免疫细胞及其与T细胞的相互作用。
Oncol Lett. 2021 Jan;21(1):57. doi: 10.3892/ol.2020.12319. Epub 2020 Nov 19.
3
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?理解非酒精性脂肪性肝病发病机制中的脂毒性:CD36 是关键驱动因素吗?
早田汁对乙肝病毒转基因小鼠高脂饮食诱导肥胖的影响。
Heliyon. 2024 Jan 10;10(2):e24438. doi: 10.1016/j.heliyon.2024.e24438. eCollection 2024 Jan 30.
Cell Death Dis. 2020 Sep 25;11(9):802. doi: 10.1038/s41419-020-03003-w.
4
Epidemiology of non-alcoholic and alcoholic fatty liver diseases.非酒精性和酒精性脂肪性肝病的流行病学
Transl Gastroenterol Hepatol. 2020 Apr 5;5:16. doi: 10.21037/tgh.2019.09.08. eCollection 2020.
5
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice.过氧化物酶体增殖物激活受体(PPARs)作为肝脏中的代谢调节剂:肝特异性 PPAR 基因敲除小鼠的启示。
Int J Mol Sci. 2020 Mar 17;21(6):2061. doi: 10.3390/ijms21062061.
6
Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.肝硬化妨碍丙型肝炎患者在接受无干扰素治疗后自然杀伤细胞表型和功能的早期和快速正常化。
Front Immunol. 2020 Feb 25;11:129. doi: 10.3389/fimmu.2020.00129. eCollection 2020.
7
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.氧化应激在非酒精性脂肪性肝病发病机制中的作用。
Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8.
8
TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging.TNF-α 驱动的炎症和线粒体功能障碍定义了衰老导致的血小板高反应性。
Blood. 2019 Aug 29;134(9):727-740. doi: 10.1182/blood.2019000200. Epub 2019 Jul 16.
9
Tumour necrosis factor signalling in health and disease.健康与疾病中的肿瘤坏死因子信号传导
F1000Res. 2019 Jan 28;8. doi: 10.12688/f1000research.17023.1. eCollection 2019.
10
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Clin Med (Lond). 2018 Jun;18(3):245-250. doi: 10.7861/clinmedicine.18-3-245.